Saturday, November 23, 2024
HomeTagsGlypican 3

Glypican 3

Eureka Therapeutics Advances ARYA-3 Clinical Trial to Phase II for Treatment of Liver Cancer Using GPC3-Targeting ARTEMIS® T-cell Therapy

Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T-cell therapies to treat cancer, announced the advancement of its ARYA-3 clinical trial to Phase...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics